FUNDAMENTALS · Fundamentals · US Healthcare

Universal Health Services (UHS) Fundamentals 2026 — P/E 6.2x, Revenue Analysis | SniperIQ

Universal Health Services (UHS) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of $9.3B, trading at

49.25 on the NYSE. This SniperIQ fundamentals page covers Universal Health Services's valuation (P/E 6.2x, P/B 1.2x), profitability (net margin 8.6%), revenue (
7.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$9.3B
P/E (TTM)6.2x
Net Margin8.6%
Revenue (FY25)
7.4B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Universal Health Services's market cap?

Universal Health Services (UHS) has a market capitalization of approximately $9.3B, trading at

49.25 on the NYSE. Market cap moves with the live share price.

What is Universal Health Services's P/E ratio?

Universal Health Services's trailing twelve-month P/E ratio is 6.2x, with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Universal Health Services?

Universal Health Services runs a net profit margin of 8.6%, a gross margin of 71.3%, and an operating margin of 11.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Universal Health Services generate?

Universal Health Services reported revenue of

7.4B for fiscal year 2025, with net income of
.5B and earnings per share (EPS) of 23.42. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Universal Health Services pay a dividend?

Universal Health Services offers a trailing dividend yield of about 0.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Universal Health Services financially healthy?

Universal Health Services carries a debt-to-equity ratio of 0.68x and a current ratio of 1.08x, with a market beta of 1.07. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Universal Health Services a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Universal Health Services (UHS) the key facts are: market cap $9.3B, P/E 6.2x, revenue

7.4B, 52-week range 140.08-246.33. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Universal Health Services's full fundamentals live

Get Universal Health Services's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Create Medic (5187) fundamentals · LBX Pharmacy Chain Joint Stock (603883) fundamentals · Wakamoto Pharmaceutical (4512) fundamentals · Halozyme Therapeutics (HALO) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons